Last updated: May 15, 2023
Sponsor: Xijing Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Inflammatory Comedones
Rash
Acne
Treatment
Fractional CO2 laser
Dezocine
Clinical Study ID
NCT05861063
XijingH-PF-20232019-F-1
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age: 18-60 years old, regardless of gender;
- Clinical diagnosis of atrophic acne scars;
- Planning to undergo ultra-pulsed CO2 lattice laser therapy;
- The patient agrees to participate in this experiment and signs an informed consentform
Exclusion
Exclusion Criteria: 1. Those who take sedative drugs for a long time; 2. Patients with sleep apnea syndrome, previous history of hypertension, and bloodpressure greater than 160/100mmHg 3. People with severe heart and lung diseases, liver and kidney diseases, psychosis,pregnancy, and communication disorders; 4. Persons who are known to be allergic to the main drug or any of the excipients inDezocine injection; 5. Increased intracranial pressure or head injury; 6. Acute and chronic alcoholism; 7. People with hypotension, hypothyroidism, acute episodes of asthma, and epilepsy
Study Design
Total Participants: 105
Treatment Group(s): 2
Primary Treatment: Fractional CO2 laser
Phase: 4
Study Start date:
February 11, 2023
Estimated Completion Date:
December 31, 2024
Connect with a study center
Dermatology Derpartment of Xijing Hospital
Xi'an, Shaanxi 710032
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.